Home>Home Page Articles>
#MobiusNeXt ... The future belongs to single-use
The future belongs to single-use
Our scalable family of Mobius® bioreactors
Without a doubt, single-use technology is revolutionizing the biopharmaceutical industry. We’re proud to have been part of this movement since its early days and look forward to shaping its future.
Our acquisition of Newport Biosystems ten years ago solidified our commitment to single-use, and we’ve never looked back. With groundbreaking technologies and products considered to be industry gold standards, we span all upstream and downsteam operations. We’re providing the tools our customers need to change the way medicines are made — whether it’s reducing the cost of manufacturing, increasing flexibility and utilization of facilities, or moving production sites closer to the patient.
Keep an eye out for new single-use products we’ll launch at INTERPHEX
(be sure to stop by booth #2841). In the meantime, visit www.emdmillipore.com/single-use
for more information about these hot topics:
- The ultimate in user-friendliness: Mobius® 2000L single-use bioreactor with an industry-leading design
- Friendly to the environment, too: An innovative, safe and fully traceable recycling process for single-use products
- Singled-minded about single-use: Q&A with Andrew Bulpin, Executive Vice President of our Process Solutions strategic marketing and innovation area
We’re proud of our history and even more excited about the future of single-use and how it will continue to transform the biopharmaceutical industry. What do you think the next ten years will hold for single-use? Dust off the crystal ball and tell us what you think. Share your thoughts and see what your peers and colleagues are predicting at #MobiusNext